Complex and cross-border healthcare transactions are Linklaters‘ greatest strength in the healthcare and life sciences sector, and clients include global investors, healthcare holding companies, and tech leaders. The practice employs a depth of expertise across legal disciplines: Rupert Bellinghausen is well-versed in arbitration and commercial litigation and leads on damages claims and medical product liability litigation; corporate law specialist Timo Engelhardt leads on high-value M&A; Julia Schönbohm brings expertise in IP and TMT law to act on healthcare data protection matters; and Jana Hager is renowned for her work in regulatory product law, and also assists on transactions.
Legal 500 Editorial commentary
Key clients
- Asahi Group Asklepios Kliniken Bayer Beiersdorf BioVersys AG Brookfield Carlyle Fresenius SE & Co. KGaA GTCR LLC Igneo Infrastructure Partners Jacobs Holding AG Siemens Healthineers AG
Work highlights
Advised Siemens Healthineers on the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis.
Advised GTCR in the bidding process to acquire a majority stake in Stada Arzneimittel AG in a competitive sale process from its existing shareholders, Bain Capital and Cinven.
Advised Carlyle Global Credit on its strategic capital investment in Orifarm Group A/S.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Other key lawyers
Rupert Bellinghausen; Timo Engelhardt; Tim Johansen-Roth; Julia Schonborn; Jana Hager